Does TACROLIMUS Cause Hypertriglyceridaemia? 110 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 110 reports of Hypertriglyceridaemia have been filed in association with TACROLIMUS (Tacrolimus). This represents 0.1% of all adverse event reports for TACROLIMUS.
110
Reports of Hypertriglyceridaemia with TACROLIMUS
0.1%
of all TACROLIMUS reports
10
Deaths
57
Hospitalizations
How Dangerous Is Hypertriglyceridaemia From TACROLIMUS?
Of the 110 reports, 10 (9.1%) resulted in death, 57 (51.8%) required hospitalization, and 20 (18.2%) were considered life-threatening.
Is Hypertriglyceridaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TACROLIMUS. However, 110 reports have been filed with the FAERS database.
What Other Side Effects Does TACROLIMUS Cause?
Off label use (8,718)
Drug ineffective (6,214)
Product use in unapproved indication (5,057)
Acute kidney injury (4,005)
Transplant rejection (3,526)
Cytomegalovirus infection (3,320)
Covid-19 (3,201)
Drug interaction (2,896)
Diarrhoea (2,854)
Toxicity to various agents (2,845)
What Other Drugs Cause Hypertriglyceridaemia?
PEGASPARGASE (399)
VINCRISTINE (373)
METHOTREXATE (372)
DEXAMETHASONE (358)
CYTARABINE (244)
CYCLOPHOSPHAMIDE (191)
QUETIAPINE (181)
MERCAPTOPURINE (176)
PREDNISONE (161)
DAUNORUBICIN (143)
Which TACROLIMUS Alternatives Have Lower Hypertriglyceridaemia Risk?
TACROLIMUS vs TACROLIMUS\TACROLIMUS ANHYDROUS
TACROLIMUS vs TADALAFIL
TACROLIMUS vs TAFAMIDIS
TACROLIMUS vs TAFAMIDIS MEGLUMINE
TACROLIMUS vs TAFASITAMAB